These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Bovine model of respiratory syncytial virus infection. Taylor G Curr Top Microbiol Immunol; 2013; 372():327-45. PubMed ID: 24362697 [TBL] [Abstract][Full Text] [Related]
4. Passive Immunization Strategies to Prevent Severe Respiratory Syncytial Virus Infection Among Newborns and Young Infants. Suryadevara M J Pediatric Infect Dis Soc; 2024 Jul; 13(Supplement_2):S110-S114. PubMed ID: 38995085 [TBL] [Abstract][Full Text] [Related]
5. A safe and efficient BCG vectored vaccine to prevent the disease caused by the human Respiratory Syncytial Virus. Rey-Jurado E; Soto J; Gálvez N; Kalergis AM Hum Vaccin Immunother; 2017 Sep; 13(9):2092-2097. PubMed ID: 28598702 [TBL] [Abstract][Full Text] [Related]
6. Protection of neonates and infants by maternal immunization. Gerdts V; van Drunen Littel-van den Hurk S; Potter A Expert Rev Vaccines; 2016 Nov; 15(11):1347-1349. PubMed ID: 27248694 [No Abstract] [Full Text] [Related]
7. Prevention of Pediatric Respiratory Syncytial Virus Lower Respiratory Tract Illness: Perspectives for the Next Decade. Aranda SS; Polack FP Front Immunol; 2019; 10():1006. PubMed ID: 31134078 [TBL] [Abstract][Full Text] [Related]
11. A Randomized, Controlled, Observer-Blinded Phase 1 Study of the Safety and Immunogenicity of a Respiratory Syncytial Virus Vaccine With or Without Alum Adjuvant. Langley JM; Aggarwal N; Toma A; Halperin SA; McNeil SA; Fissette L; Dewé W; Leyssen M; Toussaint JF; Dieussaert I J Infect Dis; 2017 Jan; 215(1):24-33. PubMed ID: 27694633 [TBL] [Abstract][Full Text] [Related]
12. Maternal awareness, acceptability and willingness towards respiratory syncytial virus (RSV) vaccination during pregnancy in Ireland. McCormack S; Thompson C; Nolan M; Imcha M; Dee A; Saunders J; Philip RK Immun Inflamm Dis; 2024 Apr; 12(4):e1257. PubMed ID: 38661110 [TBL] [Abstract][Full Text] [Related]
13. Respiratory syncytial virus in infants: is maternal vaccination a realistic strategy? Munoz FM Curr Opin Infect Dis; 2015 Jun; 28(3):221-4. PubMed ID: 25918956 [TBL] [Abstract][Full Text] [Related]
14. Efficacy of a respiratory syncytial virus vaccine candidate in a maternal immunization model. Blanco JCG; Pletneva LM; McGinnes-Cullen L; Otoa RO; Patel MC; Fernando LR; Boukhvalova MS; Morrison TG Nat Commun; 2018 May; 9(1):1904. PubMed ID: 29765035 [TBL] [Abstract][Full Text] [Related]
15. Immunopathology of RSV infection: prospects for developing vaccines without this complication. van Drunen Littel-van den Hurk S; Mapletoft JW; Arsic N; Kovacs-Nolan J Rev Med Virol; 2007; 17(1):5-34. PubMed ID: 17004293 [TBL] [Abstract][Full Text] [Related]
16. Respiratory syncytial virus vaccine research and development: World Health Organization technological roadmap and preferred product characteristics. Vekemans J; Moorthy V; Giersing B; Friede M; Hombach J; Arora N; Modjarrad K; Smith PG; Karron R; Graham B; Kaslow DC Vaccine; 2019 Nov; 37(50):7394-7395. PubMed ID: 29395536 [TBL] [Abstract][Full Text] [Related]
17. Alternative Virus-Like Particle-Associated Prefusion F Proteins as Maternal Vaccines for Respiratory Syncytial Virus. Blanco JCG; Fernando LR; Zhang W; Kamali A; Boukhvalova MS; McGinnes-Cullen L; Morrison TG J Virol; 2019 Dec; 93(23):. PubMed ID: 31511382 [TBL] [Abstract][Full Text] [Related]
18. Influenza and respiratory syncytial virus (RSV) vaccines for infants: safety, immunogenicity, and efficacy. Beeler JA; Eichelberger MC Microb Pathog; 2013 Feb; 55():9-15. PubMed ID: 23247146 [TBL] [Abstract][Full Text] [Related]